CETUXIMAB Side Effects

7022987-3 | Dehydration, Hypokalaemia, Hyponatraemia, Vomiting
on Sep 22, 2010 Female patient from GERMANY , 50 years of age, weighting 108.0 lb, was diagnosed with colorectal cancer metastatic and was treated with Cetuximab (View Usage). Patient experienced the following unwanted or unexpected effects: dehydration, hypokalaemia, hyponatraemia, vomiting. Cetuximab dosage: Inf:1;strength:5mg/ml.rec.inf On 07sep2010. Interrupted On 21sep10. During the same period patient was treated with OXALIPLATIN (1st And Rec.inf On 07-sep-2010. Interrupted On 21sep10) (View Oxaliplatin Review and Oxaliplatin Label ), FLUOROURACIL (400mg/m2 Bolus,2400mg/m2 46hrs Inf 1st,rec.inf On 07sep10 Interrupted On 21sep10) (View Fluorouracil Review and Fluorouracil Label ), FOLINIC ACID (1st And Rec.inf On 07-sep-2010. Interrupted On 21sep10) (View Folinic Acid Review and Folinic Acid Label ). Patient was hospitalized.

7022102-6 | Atrial Fibrillation
Patient was taking Cetuximab (View Usage). Patient had the following side effects: atrial fibrillation (What is atrial fibrillation?) on Sep 29, 2010 from GERMANY Additional patient health information: Male patient , 61 years of age, weighting 156.5 lb, was diagnosed with gastrooesophageal cancer and. Cetuximab dosage: Recent Inf:04aug2010; No Of Inf:3. During the same period patient was treated with CISPLATIN (Recent Inf:21jul2010 On Day 1 Of Cycle) (View Cisplatin Review and Cisplatin Label ), XELODA (Recent Inf:04aug2010 On Day 1-15) (View Xeloda Review and Xeloda Label ). Patient was hospitalized.

7022082-3 | Tumour Haemorrhage
Adverse event was reported on Sep 27, 2010 by a Male patient taking Cetuximab (View Usage) (Dosage: Recent Inf 21jan2010.cetuximab2mg/ml Actual Dose 475mg;taken8inf; 250mg/m2:standard Dose:weekly) was diagnosed with non-small cell lung cancer and. Location: GERMANY , 66 years of age, weighting 189.6 lb, After Cetuximab was administered, patient had the following side effects: tumour haemorrhage. During the same period patient was treated with CARBOPLATIN (Recent Inf On 14jan2010(3rd Inf) Auc5:q3w:4 Cycle 535mg (1 In 3 Wk)) (View Carboplatin Review and Carboplatin Label ), GEMCITABINE HCL (Recent Inf 14jan2010:3inf.1200mg/m2:d1,8,q3w For 4cycle) (View Gemcitabine Hcl Review and Gemcitabine Hcl Label ).

7020935-3 | Sepsis
on Sep 28, 2010 Female patient from JAPAN , 48 years of age, weighting 90.39 lb, was diagnosed with gastrooesophageal cancer and was treated with Cetuximab (View Usage). Patient experienced the following unwanted or unexpected effects: sepsis (What is sepsis?). Cetuximab dosage: In Total 22 Administration In 19may10(recent Inf). During the same period patient was treated with CISPLATIN (Recent Inf:15apr2010) (View Cisplatin Review and Cisplatin Label ), XELODA (On Day 1-15 Last Dose:750mg/m2 Stop Date:25jun2010 Form: Tab Recent Inf:26may2010) (View Xeloda Review and Xeloda Label ).


7019834-2 | Clostridial Infection, Pneumonia, Pulmonary Embolism
on Sep 24, 2010 Male patient from GERMANY , 64 years of age, was diagnosed with oesophageal carcinoma and was treated with Cetuximab (View Usage). Patient had the following side effects: clostridial infection, pneumonia (What is pneumonia?), pulmonary embolism (What is pulmonary embolism?). Cetuximab dosage: Interrupted On 06sep2010 450mg Recent Inf:16aug10. During the same period patient was treated with CISPLATIN (Interrupted On 23aug10 Recent Inf:02aug10) (View Cisplatin Review and Cisplatin Label ), CAPECITABINE (Interrupted On 12sep10 Recent Inf:19aug10) (View Capecitabine Review and Capecitabine Label ). Patient was hospitalized.

7018740-7 | Aspiration, Mucosal Inflammation
Patient was taking Cetuximab (View Usage). After Cetuximab was administered, patient had the following side effects: aspiration, mucosal inflammation on Sep 23, 2010 from UNITED STATES Additional patient health information: Male patient , 77 years of age, was diagnosed with head and neck cancer (What is head and neck cancer?), prophylaxis, pain (What is pain?), constipation (What is constipation?), mucosal inflammation and. Cetuximab dosage: Recent Inf:24aug10 8jun10:400 Mg/m2 (1d) Unk::24aug10:250mg/m2 Weekly Discontinued On 6sep10. During the same period patient was treated with CISPLATIN (Recent Inf:17aug10 Discontinued On 6sep10) (View Cisplatin Review and Cisplatin Label ), PEMETREXED DISODIUM (Recent Inf:17aug10 Discontinued On 6sep10) (View Pemetrexed Disodium Review and Pemetrexed Disodium Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ), VITAMIN B 12 (View Vitamin B-12 Review and Vitamin B-12 Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ), FENTANYL CITRATE (View Fentanyl Citrate Review and Fentanyl Citrate Label ), IMPORTAL (View Importal Review and Importal Label ), MYCOSTATIN (View Mycostatin Review and Mycostatin Label ). Patient was hospitalized.

7018736-5 | Interstitial Lung Disease
Adverse event was reported on Sep 23, 2010 by a Male patient taking Cetuximab (View Usage) (Dosage: 500mg/m2 1 In 2w-17may10,cetuximab 5mg/ml; Recent Infusion On 30apr10(20th Administration In Total)) was diagnosed with non-small cell lung cancer and. Location: GERMANY , 67 years of age, weighting 235.9 lb, Patient experienced the following unwanted or unexpected effects: interstitial lung disease. During the same period patient was treated with CARBOPLATIN (On Day 1 Of 21 Day Cycle) (View Carboplatin Review and Carboplatin Label ), PACLITAXEL (On Day 1 Of 21 Day Cycle) (View Paclitaxel Review and Paclitaxel Label ). Patient was hospitalized.

7017384-0 | Embolism Arterial
on Sep 20, 2010 Female patient from GERMANY , 56 years of age, weighting 110.2 lb, was diagnosed with gastrooesophageal cancer and was treated with Cetuximab (View Usage). Patient had the following side effects: embolism arterial. Cetuximab dosage: Formulation:5mg/ml,recent Inf:13sep10,no Of Inf:1,interrupted:20sep10. During the same period patient was treated with CISPLATIN (Dosage:on Day 1 Of Cycle,recent Inf:13sep10,interrupted:20sep10) (View Cisplatin Review and Cisplatin Label ), XELODA (Dosage:on Day1-15,recent Inf:19sep10,interrupted:20sep10,duration:6days) (View Xeloda Review and Xeloda Label ). Patient was hospitalized.

7015626-9 | Cardiopulmonary Failure, Haemorrhage, Malignant Neoplasm Progression, Post Procedural Haemorrhage
on Sep 20, 2010 Male patient from GERMANY , 50 years of age, weighting 176.4 lb, was diagnosed with head and neck cancer (What is head and neck cancer?) and was treated with Cetuximab (View Usage). After Cetuximab was administered, patient had the following side effects: cardiopulmonary failure, haemorrhage, malignant neoplasm progression, post procedural haemorrhage. Cetuximab dosage: Recent Inf 16th Inf On 10aug2010;5mg/ml.. During the same period patient was treated with CISPLATIN (Recent Infusion 03aug2010(5th Inf).) (View Cisplatin Review and Cisplatin Label ), FLUOROURACIL (Taken On Day 1 To Day 4 Of Cycle. Recent Inf 03aug2010 (5th Inf).) (View Fluorouracil Review and Fluorouracil Label ).

7015622-1 | Multi-organ Failure, Pulmonary Embolism
Patient was taking Cetuximab (View Usage). Patient experienced the following unwanted or unexpected effects: multi-organ failure, pulmonary embolism (What is pulmonary embolism?) on Sep 21, 2010 from GERMANY Additional patient health information: Male patient , 64 years of age, was diagnosed with oesophageal carcinoma and. Cetuximab dosage: Interrupted On 06sep2010 450mg Recent Inf:16aug10. During the same period patient was treated with CISPLATIN (Interrupted On 23aug10 Recent Inf:02aug10) (View Cisplatin Review and Cisplatin Label ), CAPECITABINE (Interrupted On 12sep10 Recent Inf:19aug10) (View Capecitabine Review and Capecitabine Label ). Patient was hospitalized.

7015621-X | Post Procedural Fistula, Radiation Skin Injury
Adverse event was reported on Sep 22, 2010 by a Male patient taking Cetuximab (View Usage) (Dosage: ) was diagnosed with head and neck cancer (What is head and neck cancer?) and. Location: GERMANY , 58 years of age, Patient had the following side effects: post procedural fistula, radiation skin injury. Patient was hospitalized.

7015593-8 | Pneumonia Primary Atypical
on Sep 23, 2010 Female patient from GERMANY , 61 years of age, was diagnosed with non-small cell lung cancer and was treated with Cetuximab (View Usage). After Cetuximab was administered, patient had the following side effects: pneumonia primary atypical. Cetuximab dosage: Recent Inf:28jun2010. During the same period patient was treated with CISPLATIN (Recent Inf:29jun10) (View Cisplatin Review and Cisplatin Label ). Patient was hospitalized.

7014804-2 | Sepsis
on Sep 21, 2010 Female patient from GERMANY , 48 years of age, weighting 90.39 lb, was diagnosed with gastrooesophageal cancer and was treated with Cetuximab (View Usage). Patient experienced the following unwanted or unexpected effects: sepsis (What is sepsis?). Cetuximab dosage: In Total 22 Administration In 19may10(recent Inf). During the same period patient was treated with CISPLATIN (Recent Inf:15apr2010) (View Cisplatin Review and Cisplatin Label ), XELODA (On Day 1-15 Last Dose:750mg/m2 Stop Date:25jun2010 Form: Tab Recent Inf:26may2010) (View Xeloda Review and Xeloda Label ).

7014802-9 | Acute Hepatic Failure, Febrile Neutropenia, Thrombocytopenia
Patient was taking Cetuximab (View Usage). Patient had the following side effects: acute hepatic failure, febrile neutropenia, thrombocytopenia on Sep 20, 2010 from GERMANY Additional patient health information: Male patient , 56 years of age, weighting 205.0 lb, was diagnosed with head and neck cancer (What is head and neck cancer?) and. Cetuximab dosage: Strength:5mg/ml. During the same period patient was treated with CISPLATIN (View Cisplatin Review and Cisplatin Label ), CILENGITIDE (Last Dose On:27aug2010 No Of Inf:2) (View Cilengitide Review and Cilengitide Label ), FLUOROURACIL (Recent Inf:27aug2010 No Of Inf:4) (View Fluorouracil Review and Fluorouracil Label ). Patient was hospitalized.

7014796-6 | Ischaemic Stroke
Adverse event was reported on Sep 24, 2010 by a Male patient taking Cetuximab (View Usage) (Dosage: Given On 19jan2010. Cetuximab 5mg/ml) was diagnosed with non-small cell lung cancer and. Location: GERMANY , 73 years of age, weighting 185.2 lb, After Cetuximab was administered, patient had the following side effects: ischaemic stroke. During the same period patient was treated with CISPLATIN (Dose Frequency: Day1 Of 21 Day Cycle.) (View Cisplatin Review and Cisplatin Label ), VINORELBINE (Interrupted On 12jan10 Dose Frequency:days 1,8 Of 21 Day Cycle.) (View Vinorelbine Review and Vinorelbine Label ).

7013410-3 | Chest Pain
on Sep 23, 2010 Female patient from GERMANY , 48 years of age, weighting 180.8 lb, was diagnosed with gastrooesophageal cancer and was treated with Cetuximab (View Usage). Patient experienced the following unwanted or unexpected effects: chest pain (What is chest pain?). Cetuximab dosage: Most Recent Inf:03sep2010. During the same period patient was treated with CISPLATIN (On Day 1 Of Cycle:most Recent Inf:27aug2010) (View Cisplatin Review and Cisplatin Label ), CAPECITABINE (On Day 1-15:most Recent Inf:10sep2010) (View Capecitabine Review and Capecitabine Label ). Patient was hospitalized.

7013408-5 | Blood Bilirubin Increased, Cytolytic Hepatitis, Pyrexia, Sepsis
on Sep 21, 2010 Male patient from GERMANY , 52 years of age, weighting 149.9 lb, was diagnosed with gastrooesophageal cancer and was treated with Cetuximab (View Usage). Patient had the following side effects: blood bilirubin increased, cytolytic hepatitis, pyrexia, sepsis (What is sepsis?). Cetuximab dosage: Strength: 5mg/ml. During the same period patient was treated with CISPLATIN (Taken On Day 1 Of Cycle.) (View Cisplatin Review and Cisplatin Label ), XELODA (Taken On Day 1-15.) (View Xeloda Review and Xeloda Label ). Patient was hospitalized and became disabled.

7012487-9 | Haemoglobin Decreased, Malignant Neoplasm Progression, Platelet Count Decreased, Red Blood Cell Count Decreased, White Blood Cell Count Decreased
Patient was taking Cetuximab (View Usage). After Cetuximab was administered, patient had the following side effects: haemoglobin decreased, malignant neoplasm progression, platelet count decreased, red blood cell count decreased, white blood cell count decreased on Sep 17, 2010 from GERMANY Additional patient health information: Male patient , 50 years of age, weighting 176.4 lb, was diagnosed with head and neck cancer (What is head and neck cancer?) and. Cetuximab dosage: Recent Inf 16th Inf On 10aug2010. During the same period patient was treated with CISPLATIN (Recent Infusion 3aug2010) (View Cisplatin Review and Cisplatin Label ), FLUOROURACIL (Taken On Day 1 To Day 4 Of Cycle. Recent Inf 3aug2010) (View Fluorouracil Review and Fluorouracil Label ).

7012483-1 | Deep Vein Thrombosis
Adverse event was reported on Sep 22, 2010 by a Female patient taking Cetuximab (View Usage) (Dosage: Rec Inf + Temp Discont: 01jul2010 No Of Inf: 6 Restarted 27jul2010) was diagnosed with gastrooesophageal cancer and. Location: JAPAN , 63 years of age, weighting 105.8 lb, Patient experienced the following unwanted or unexpected effects: deep vein thrombosis (What is deep vein thrombosis?). During the same period patient was treated with CISPLATIN (On Day 1 Rec Inf +temp Discont: 18jun2010 Restarted 27jul2010) (View Cisplatin Review and Cisplatin Label ), XELODA (Rec Inf+temp Discont: 02jul2010 Restarted 27jul2010 Dose Reduced To 750mg/m2) (View Xeloda Review and Xeloda Label ). Patient was hospitalized.

7012482-X | Pulmonary Embolism
on Sep 20, 2010 Male patient from UNITED STATES , 77 years of age, weighting 138.9 lb, was diagnosed with non-small cell lung cancer and was treated with Cetuximab (View Usage). Patient had the following side effects: pulmonary embolism (What is pulmonary embolism?). Cetuximab dosage: 60 Mg (420 Mg, 1 In 1week),11aug-18aug; 420 Mg (18aug-18aug10). During the same period patient was treated with CARBOPLATIN (12.8571 Mg (270 Mg, 1 In 3 Weeks)) (View Carboplatin Review and Carboplatin Label ), GEMCITABINE (View Gemcitabine Review and Gemcitabine Label ), PLAVIX (View Plavix Review and Plavix Label ), PRAVASTATIN SODIUM (View Pravastatin Sodium Review and Pravastatin Sodium Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ), PREDNISONE (View Prednisone Review and Prednisone Label ), ADVAIR DISKUS 100/50 (View Advair Diskus 100/50 Review and Advair Diskus 100/50 Label ), GUAIFENESIN (At Night) (View Guaifenesin Review and Guaifenesin Label ).

7009958-8 | Malignant Neoplasm Progression
on Sep 15, 2010 Male patient from GERMANY , 41 years of age, was diagnosed with non-small cell lung cancer and was treated with Cetuximab (View Usage). After Cetuximab was administered, patient had the following side effects: malignant neoplasm progression. Cetuximab dosage: 5mg/ml. During the same period patient was treated with CISPLATIN (View Cisplatin Review and Cisplatin Label ), GEMCITABINE (Day 1,8 Of 21 Day Cycle) (View Gemcitabine Review and Gemcitabine Label ).

7009328-2 | Deep Vein Thrombosis
Patient was taking Cetuximab (View Usage). Patient experienced the following unwanted or unexpected effects: deep vein thrombosis (What is deep vein thrombosis?) on Sep 16, 2010 from GERMANY Additional patient health information: Male patient , 67 years of age, weighting 108.0 lb, was diagnosed with gastrooesophageal cancer and. Cetuximab dosage: Most Recent Infusion On 01jun2010.no:4.. During the same period patient was treated with CISPLATIN (Day 1 Of Cycle) (View Cisplatin Review and Cisplatin Label ), CAPECITABINE (On Day Of 1-15. Last Inf: 10may2010) (View Capecitabine Review and Capecitabine Label ).

7009276-8 | Decreased Appetite
Adverse event was reported on Sep 16, 2010 by a Female patient taking Cetuximab (View Usage) (Dosage: 9th Inf On 30jul2010;5mg/ml.) was diagnosed with gastrooesophageal cancer and. Location: GERMANY , 72 years of age, weighting 141.1 lb, Patient had the following side effects: decreased appetite. During the same period patient was treated with CISPLATIN (Day 1 Of Cycle.) (View Cisplatin Review and Cisplatin Label ), XELODA (Tabs, On Day 1-15; Recent Dose On 01aug2010.) (View Xeloda Review and Xeloda Label ). Patient was hospitalized.

7009273-2 | Dizziness, Headache, Vision Blurred
on Sep 21, 2010 Male patient from UNITED STATES , 69 years of age, was diagnosed with metastatic gastric cancer and was treated with Cetuximab (View Usage). After Cetuximab was administered, patient had the following side effects: dizziness (What is dizziness?), headache (What is headache?), vision blurred. Cetuximab dosage: Interrupted On (19nov09). During the same period patient was treated with XELODA (Interrupted On 25nov09) (View Xeloda Review and Xeloda Label ), OXALIPLATIN (19-19jun2009 11-11nov2009 Every Cycle) (View Oxaliplatin Review and Oxaliplatin Label ), REGLAN (View Reglan Review and Reglan Label ), LOPERAMIDE (View Loperamide Review and Loperamide Label ), ZOFRAN (View Zofran Review and Zofran Label ), COMPAZINE (View Compazine Review and Compazine Label ), ENALAPRIL (View Enalapril Review and Enalapril Label ), NORVASC (View Norvasc Review and Norvasc Label ). Patient was hospitalized.

7009270-7 | Localised Oedema
on Sep 14, 2010 Female patient from GERMANY , 57 years of age, weighting 138.9 lb, was diagnosed with head and neck cancer (What is head and neck cancer?) and was treated with Cetuximab (View Usage). Patient experienced the following unwanted or unexpected effects: localised oedema. Cetuximab dosage: Strength:5mg/ml. Patient was hospitalized.

7009269-0 | Hyponatraemia, Oedema Peripheral, Renal Impairment, Stomatitis
Patient was taking Cetuximab (View Usage). Patient had the following side effects: hyponatraemia, oedema peripheral, renal impairment, stomatitis on Sep 14, 2010 from GERMANY Additional patient health information: Male patient , 56 years of age, weighting 160.9 lb, was diagnosed with head and neck cancer (What is head and neck cancer?) and. Cetuximab dosage: . During the same period patient was treated with CISPLATIN (View Cisplatin Review and Cisplatin Label ), CILENGITIDE (View Cilengitide Review and Cilengitide Label ), FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ). Patient was hospitalized.

7009262-8 | Haemorrhage
Adverse event was reported on Sep 20, 2010 by a Male patient taking Cetuximab (View Usage) (Dosage: 1st Infu) was diagnosed with lip and/or oral cavity cancer and. Location: GERMANY , 39 years of age, weighting 130.1 lb, After Cetuximab was administered, patient had the following side effects: haemorrhage. During the same period patient was treated with CISPLATIN (1st Infu) (View Cisplatin Review and Cisplatin Label ), FLUOROURACIL (1st Infu) (View Fluorouracil Review and Fluorouracil Label ). Patient was hospitalized.

7007147-4 | Cerebral Ischaemia, Gastrointestinal Haemorrhage
on Aug 13, 2010 Male patient from GERMANY , 70 years of age, was diagnosed with oesophageal carcinoma and was treated with Cetuximab (View Usage). Patient experienced the following unwanted or unexpected effects: cerebral ischaemia, gastrointestinal haemorrhage. Cetuximab dosage: Recent Inf:23jun2010;. During the same period patient was treated with CISPLATIN (Last Dose On 22jun2009;dose Reduced To 30mg/me2;) (View Cisplatin Review and Cisplatin Label ), XELODA (Capecitabine Tabs) (View Xeloda Review and Xeloda Label ). Patient was hospitalized.

7005797-2 | Acute Hepatic Failure, Febrile Neutropenia, Thrombocytopenia
on Sep 15, 2010 Male patient from GERMANY , 56 years of age, weighting 205.0 lb, was diagnosed with head and neck cancer (What is head and neck cancer?) and was treated with Cetuximab (View Usage). Patient had the following side effects: acute hepatic failure, febrile neutropenia, thrombocytopenia. Cetuximab dosage: . During the same period patient was treated with CISPLATIN (View Cisplatin Review and Cisplatin Label ), CILENGITIDE (Last Dose On:27aug2010 No Of Inf:2) (View Cilengitide Review and Cilengitide Label ), FLUOROURACIL (Recent Inf:27aug2010 No Of Inf:4) (View Fluorouracil Review and Fluorouracil Label ).

7005204-X | Anaphylactic Reaction
Patient was taking Cetuximab (View Usage). After Cetuximab was administered, patient had the following side effects: anaphylactic reaction on Sep 20, 2010 from UNITED STATES Additional patient health information: Male patient , 62 years of age, weighting 186.0 lb, was diagnosed with oesophageal carcinoma and. Cetuximab dosage: 800 Mg Ud Iv.

7004949-5 | Cerebrovascular Accident
Adverse event was reported on Sep 13, 2010 by a Male patient taking Cetuximab (View Usage) (Dosage: Most Recent Inf: 28jan2010 Interrupted On 04feb2010) was diagnosed with non-small cell lung cancer and. Location: GERMANY , 54 years of age, weighting 99.21 lb, Patient experienced the following unwanted or unexpected effects: cerebrovascular accident. During the same period patient was treated with PACLITAXEL (Most Recent Inf: 29jan10,day 1 Of 21 Day Cycle Interrupted On 04feb2010) (View Paclitaxel Review and Paclitaxel Label ), CARBOPLATIN (1 Df = 6 Auc,day 1 Of 21 Day Cycle,most Recent Inf:29jan10 Interrupted On 04feb2010) (View Carboplatin Review and Carboplatin Label ). Patient was hospitalized.

7002464-6 | Pneumonia Primary Atypical
on Sep 13, 2010 Female patient from GERMANY , 61 years of age, was diagnosed with non-small cell lung cancer and was treated with Cetuximab (View Usage). Patient had the following side effects: pneumonia primary atypical. Cetuximab dosage: Recent Inf:28jun2010. During the same period patient was treated with CISPLATIN (Recent Inf:29jun10) (View Cisplatin Review and Cisplatin Label ). Patient was hospitalized.

7002445-2 |
on Sep 14, 2010 Male patient from GERMANY , 50 years of age, weighting 176.4 lb, was diagnosed with head and neck cancer (What is head and neck cancer?) and was treated with Cetuximab (View Usage). . Cetuximab dosage: Recent Inf 16th Inf On 10aug2010. During the same period patient was treated with CISPLATIN (Recent Infusion 3aug2010) (View Cisplatin Review and Cisplatin Label ), FLUOROURACIL (Taken On Day 1 To Day 4 Of Cycle. Recent Inf 3aug2010) (View Fluorouracil Review and Fluorouracil Label ).

6999805-2 | Pulmonary Embolism
Patient was taking Cetuximab (View Usage). Patient experienced the following unwanted or unexpected effects: pulmonary embolism (What is pulmonary embolism?) on Sep 13, 2010 from UNITED STATES Additional patient health information: Male patient , 77 years of age, weighting 138.9 lb, was diagnosed with non-small cell lung cancer and. Cetuximab dosage: 60 Mg (420 Mg, 1 In 1week),11aug-18aug; 420 Mg (18aug-18aug10). During the same period patient was treated with CARBOPLATIN (12.8571 Mg (270 Mg, 1 In 3 Weeks)) (View Carboplatin Review and Carboplatin Label ), GEMCITABINE (View Gemcitabine Review and Gemcitabine Label ), PLAVIX (View Plavix Review and Plavix Label ), PRAVASTATIN SODIUM (View Pravastatin Sodium Review and Pravastatin Sodium Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ), PREDNISONE (View Prednisone Review and Prednisone Label ), ADVAIR DISKUS 100/50 (View Advair Diskus 100/50 Review and Advair Diskus 100/50 Label ), GUAIFENESIN (At Night) (View Guaifenesin Review and Guaifenesin Label ).

6999801-5 | Deep Vein Thrombosis
Adverse event was reported on Sep 10, 2010 by a Male patient taking Cetuximab (View Usage) (Dosage: Recent Inf:09aug2010 Tot:5) was diagnosed with gastrooesophageal cancer and. Location: GERMANY , 61 years of age, weighting 123.5 lb, Patient had the following side effects: deep vein thrombosis (What is deep vein thrombosis?). During the same period patient was treated with CISPLATIN (Recent Inf:02aug2010, On Day 1 Of Cycle. Ongoing) (View Cisplatin Review and Cisplatin Label ), XELODA (Recent Inf:09aug2010, On Day 1-15. Tablet;ongoing) (View Xeloda Review and Xeloda Label ). Patient was hospitalized.

6999798-8 | Bone Marrow Failure, Pancytopenia, Post Procedural Complication, Thrombophlebitis
on Sep 13, 2010 Female patient from AUSTRALIA , 44 years of age, weighting 127.9 lb, was diagnosed with non-small cell lung cancer and was treated with Cetuximab (View Usage). After Cetuximab was administered, patient had the following side effects: bone marrow failure, pancytopenia, post procedural complication, thrombophlebitis. Cetuximab dosage: Cetuximab 5 Mg/ml Recent Infusion:06may2010. 18feb10-13may10(83d) Restarted On 29may10-ongoing. During the same period patient was treated with CARBOPLATIN (On Day 1 Of 21-day Cycle;1df=4auc Recent Infusion:29apr10 Reduced To 4 Auc) (View Carboplatin Review and Carboplatin Label ), GEMCITABINE (Recent Infusion:06may10 Day 1,8 Of 21-day Cycle) (View Gemcitabine Review and Gemcitabine Label ). Patient was hospitalized.

6997764-X | Deep Vein Thrombosis
on Sep 15, 2010 Male patient from GERMANY , 45 years of age, weighting 163.1 lb, was diagnosed with colorectal cancer metastatic and was treated with Cetuximab (View Usage). Patient experienced the following unwanted or unexpected effects: deep vein thrombosis (What is deep vein thrombosis?). Cetuximab dosage: Recent Inf: 30aug2010(9th Inf).. During the same period patient was treated with IRINOTECAN HCL (Recent Inf: 30aug2010(9th Inf).) (View Irinotecan Hcl Review and Irinotecan Hcl Label ), FLUOROURACIL (Recent Inf: 30aug2010(9th Inf);400mg/m2 Bolus,2400mg/m2 46 Hrs Infusion.) (View Fluorouracil Review and Fluorouracil Label ), FOLINIC ACID (Recent Inf:30aug2010 No Of Inf:9) (View Folinic Acid Review and Folinic Acid Label ).

6997763-8 | Malnutrition
Patient was taking Cetuximab (View Usage). Patient had the following side effects: malnutrition on Sep 10, 2010 from GERMANY Additional patient health information: Female patient , 45 years of age, weighting 61.73 lb, was diagnosed with head and neck cancer (What is head and neck cancer?) and. Cetuximab dosage: Strength:2mg/ml Recent Infusion On 09sep10 (250mg/m2, 18th Infusion)..

6993009-5 | Headache, Paraesthesia
Adverse event was reported on Sep 15, 2010 by a Female patient taking Cetuximab (View Usage) (Dosage: Recent Inf:09mar2010) was diagnosed with colon cancer and. Location: GERMANY , 43 years of age, After Cetuximab was administered, patient had the following side effects: headache (What is headache?), paraesthesia. During the same period patient was treated with OXALIPLATIN (Recent Inf:04mar2010) (View Oxaliplatin Review and Oxaliplatin Label ), FLUOROURACIL (Recent Inf:05mar2010) (View Fluorouracil Review and Fluorouracil Label ), FOLINIC ACID (Recent Inf:05mar2010) (View Folinic Acid Review and Folinic Acid Label ). Patient was hospitalized.

6992986-6 | Acute Hepatic Failure
on Sep 15, 2010 Male patient from GERMANY , 56 years of age, weighting 205.0 lb, was diagnosed with head and neck cancer (What is head and neck cancer?) and was treated with Cetuximab (View Usage). Patient experienced the following unwanted or unexpected effects: acute hepatic failure. Cetuximab dosage: . During the same period patient was treated with CISPLATIN FOR INJ (View Cisplatin For Inj Review and Cisplatin For Inj Label ), CILENGITIDE (Last Dose On:27aug2010 No Of Inf:2) (View Cilengitide Review and Cilengitide Label ), FLUOROURACIL (Recent Inf:27aug2010 No Of Inf:4) (View Fluorouracil Review and Fluorouracil Label ).

6992980-5 | Ischaemic Stroke
on Sep 15, 2010 Male patient from GERMANY , 73 years of age, weighting 185.2 lb, was diagnosed with non-small cell lung cancer and was treated with Cetuximab (View Usage). Patient had the following side effects: ischaemic stroke. Cetuximab dosage: Given On 19jan2010. Cetuximab 5mg/ml. During the same period patient was treated with CISPLATIN FOR INJ (Dose Frequency: Day1 Of 21 Day Cycle.) (View Cisplatin For Inj Review and Cisplatin For Inj Label ), VINORELBINE (Interrupted On 12jan10 Dose Frequency:days 1,8 Of 21 Day Cycle.) (View Vinorelbine Review and Vinorelbine Label ).

6992244-X | Decreased Appetite
Patient was taking Cetuximab (View Usage). After Cetuximab was administered, patient had the following side effects: decreased appetite on Sep 10, 2010 from JAPAN Additional patient health information: Male patient , 59 years of age, weighting 114.6 lb, was diagnosed with head and neck cancer (What is head and neck cancer?), mineral supplementation and. Cetuximab dosage: Recent Inf:26aug10 Strength:5mg/ml No Of Inf:14. During the same period patient was treated with CISPLATIN (Recent Inf:20aug10 No Of Inf:5) (View Cisplatin Review and Cisplatin Label ), FLUOROURACIL (As Cont.inf From D1-4 Of Cycle Recent Inf:24aug10 No Of Inf:20) (View Fluorouracil Review and Fluorouracil Label ), ALFACALCIDOL (View Alfacalcidol Review and Alfacalcidol Label ), LEVOTHYROXINE (View Levothyroxine Review and Levothyroxine Label ), CALCIUM LACTATE (View Calcium Lactate Review and Calcium Lactate Label ). Patient was hospitalized.

6992241-4 | Febrile Bone Marrow Aplasia
Adverse event was reported on Sep 09, 2010 by a Male patient taking Cetuximab (View Usage) (Dosage: 5mg/ml;recent Inf 17dec09;interrupted On 23dec09; Restarted 05jan2010. 09dec-23dec10:14d) was diagnosed with non-small cell lung cancer and. Location: GERMANY , 62 years of age, weighting 174.2 lb, Patient experienced the following unwanted or unexpected effects: febrile bone marrow aplasia. During the same period patient was treated with CISPLATIN (3.0895mg/m2(80mg/m2 D1 Of 21d Cycle) Interrupted 23dec09 Restarted 05jan2010 09dec-23dec10:14d) (View Cisplatin Review and Cisplatin Label ), VINORELBINE (D1,8 Of 21d Cycle;recent Inf On 17dec09 Interrupted 23dec09 Restarted 05jan2010 09dec-23dec10:14d) (View Vinorelbine Review and Vinorelbine Label ). Patient was hospitalized.

6992239-6 | Oesophagitis
on Sep 08, 2010 Male patient from UNITED STATES , 75 years of age, was diagnosed with head and neck cancer (What is head and neck cancer?), prophylaxis and was treated with Cetuximab (View Usage). Patient had the following side effects: oesophagitis. Cetuximab dosage: Day 1 Of Cycle 1, Then 250mg/m2. Last Dose On 16jul10. During the same period patient was treated with CISPLATIN (Recent Dose On 02jul10) (View Cisplatin Review and Cisplatin Label ), PEMETREXED DISODIUM (Recent Dose On 02jul10) (View Pemetrexed Disodium Review and Pemetrexed Disodium Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ), VITAMIN B 12 (View Vitamin B-12 Review and Vitamin B-12 Label ). Patient was hospitalized.

6992229-3 | Hypokalaemia, Hypophosphataemia, Infection, Orthostatic Hypotension
on Sep 08, 2010 Female patient from UNITED STATES , 61 years of age, weighting 293.2 lb, was diagnosed with non-small cell lung cancer, hypertension, pain (What is pain?), convulsion, anxiety (What is anxiety?), depression (What is depression?), vertigo, gastrooesophageal reflux disease and was treated with Cetuximab (View Usage). After Cetuximab was administered, patient had the following side effects: hypokalaemia, hypophosphataemia, infection (What is infection?), orthostatic hypotension. Cetuximab dosage: Taken Till 29jul10(44th Inf)(380d) Resumed On 12aug2010. During the same period patient was treated with PEMETREXED DISODIUM (Taken Till 27oct09(6th Inf)) (View Pemetrexed Disodium Review and Pemetrexed Disodium Label ), LOPRESSOR (View Lopressor Review and Lopressor Label ), LORTAB (1 Df = 7.5/500mg, 1 Tab Every 6 Hrs) (View Lortab Review and Lortab Label ), LAMICTAL (View Lamictal Review and Lamictal Label ), ATIVAN (As Needed) (View Ativan Review and Ativan Label ), MECLIZINE (As Needed) (View Meclizine Review and Meclizine Label ), NEXIUM (View Nexium Review and Nexium Label ). Patient was hospitalized.

6992208-6 |
Patient was taking Cetuximab (View Usage). on Sep 14, 2010 from GERMANY Additional patient health information: Male patient , 41 years of age, was diagnosed with non-small cell lung cancer and. Cetuximab dosage: 5mg/ml. During the same period patient was treated with CISPLATIN (View Cisplatin Review and Cisplatin Label ), GEMCITABINE (Day 1,8 Of 21 Day Cycle) (View Gemcitabine Review and Gemcitabine Label ).

6992207-4 | Epistaxis, Febrile Neutropenia, Neutrophil Count Decreased, Platelet Count Decreased
Adverse event was reported on Sep 14, 2010 by a Male patient taking Cetuximab (View Usage) (Dosage: On Day 1 Every 21 Days With Subsequent Dose 250mg/m2 Given Weekly Iv On 28aug10 C1d8 Dose) was diagnosed with head and neck cancer (What is head and neck cancer?), cardiovascular disorder, nausea (What is nausea?), dermatitis acneiform and. Location: UNITED STATES , 71 years of age, weighting 242.5 lb, Patient had the following side effects: epistaxis, febrile neutropenia, neutrophil count decreased, platelet count decreased. During the same period patient was treated with CARBOPLATIN (1 Df=5 Auc 5 On Day 1 Every 21 Days) (View Carboplatin Review and Carboplatin Label ), ALIMTA (On Day 1 Every 21 Days) (View Alimta Review and Alimta Label ), VITAMIN B 12 (View Vitamin B-12 Review and Vitamin B-12 Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), ZOFRAN (View Zofran Review and Zofran Label ), COMPAZINE (View Compazine Review and Compazine Label ), CLINDAMYCIN (View Clindamycin Review and Clindamycin Label ). Patient was hospitalized.

6992204-9 | Multi-organ Failure
on Sep 13, 2010 Male patient from GERMANY , 63 years of age, weighting 253.5 lb, was diagnosed with non-small cell lung cancer and was treated with Cetuximab (View Usage). After Cetuximab was administered, patient had the following side effects: multi-organ failure. Cetuximab dosage: . During the same period patient was treated with CARBOPLATIN (View Carboplatin Review and Carboplatin Label ), PACLITAXEL (View Paclitaxel Review and Paclitaxel Label ), ATENOLOL (View Atenolol Review and Atenolol Label ), LOSARTAN POTASSIUM (View Losartan Potassium Review and Losartan Potassium Label ), AMIODARONE HCL (View Amiodarone Hcl Review and Amiodarone Hcl Label ), IBUPROFEN (View Ibuprofen Review and Ibuprofen Label ), METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ). Patient was hospitalized.

6992200-1 | Thrombocytopenia
on Sep 13, 2010 Male patient from UNITED STATES , 66 years of age, weighting 200.6 lb, was diagnosed with non-small cell lung cancer and was treated with Cetuximab (View Usage). Patient experienced the following unwanted or unexpected effects: thrombocytopenia. Cetuximab dosage: Received A Dose On 28jun10. During the same period patient was treated with TAXOL (Received A Dose On 28jun10,02aug10) (View Taxol Review and Taxol Label ), CARBOPLATIN (Received A Dose On 28jun10,02aug10) (View Carboplatin Review and Carboplatin Label ).

6988576-1 | Hypocalcaemia, Hypokalaemia, Hyponatraemia, Hypotension
Patient was taking Cetuximab (View Usage). Patient had the following side effects: hypocalcaemia, hypokalaemia, hyponatraemia, hypotension on Sep 09, 2010 from GERMANY Additional patient health information: Male patient , 53 years of age, weighting 138.9 lb, was diagnosed with head and neck cancer (What is head and neck cancer?), hypertension and. Cetuximab dosage: 5mg/ml. During the same period patient was treated with CISPLATIN (Inf-2) (View Cisplatin Review and Cisplatin Label ), CILENGITIDE (View Cilengitide Review and Cilengitide Label ), FLUOROURACIL (Continuous Inf From Day 1 To Day 4 Of Cycle;) (View Fluorouracil Review and Fluorouracil Label ), CLONIDINE (View Clonidine Review and Clonidine Label ). Patient was hospitalized.